(Q37083386)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270857%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

review article

1 reference

title

The role of anti-cyclic cytrullinate antibodies testing in rheumatoid arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270857%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270857%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Mariagrazia Modesti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270857%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Roberta Priori

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270857%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Riccardo Mancini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270857%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Guido Valesini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270857%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

1 February 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270857%20AND%20SRC:MED&resulttype=core&format=json

Clinical Reviews in Allergy & Immunology

2 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270857%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270857%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270857%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

45-49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270857%20AND%20SRC:MED&resulttype=core&format=json

The devil in the details: the emerging role of anticitrulline autoimmunity in rheumatoid arthritis

2 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12016-007-8023-4

The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12016-007-8023-4

Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study

21 January 2018

1 reference

12 December 2020

Arthritis of the large joints - in particular, the knee - at first presentation is predictive for a high level of radiological destruction of the small joints in rheumatoid arthritis

1 reference

12 December 2020

The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis

1 reference

12 December 2020

Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.

1 reference

12 December 2020

Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis

1 reference

12 December 2020

Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren's syndrome

1 reference

12 December 2020

Isotype distribution of ANTI–CYCLIC citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response

1 reference

12 December 2020

The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis

1 reference

12 December 2020

Presence of antibodies against cyclic citrullinated peptides in patients with 'rhupus': a cross-sectional study

1 reference

12 December 2020

Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review

1 reference

12 December 2020

Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus

1 reference

12 December 2020

The presence of citrullinated proteins is not specific for rheumatoid synovial tissue

1 reference

12 December 2020

Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis

1 reference

12 December 2020

Antibodies to cyclic citrullinated peptides in psoriatic arthritis

1 reference

12 December 2020

Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia

1 reference

12 December 2020

The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide

1 reference

12 December 2020

Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis

1 reference

12 December 2020

Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement

1 reference

12 December 2020

Absence of antibody to cyclic citrullinated peptide in sera of non-arthritic patients with chronic hepatitis B virus infection

1 reference

12 December 2020

Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis.

1 reference

12 December 2020

Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis.

1 reference

12 December 2020

Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage

1 reference

12 December 2020

Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease

1 reference

12 December 2020

Positive anti-cyclic citrullinated proteins and rheumatoid factor during active lung tuberculosis

1 reference

12 December 2020

Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis

1 reference

12 December 2020

Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement

1 reference

12 December 2020

Use of antibodies recognizing cyclic citrullinated peptide in the differential diagnosis of joint involvement in systemic sclerosis

1 reference

12 December 2020

Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome

1 reference

12 December 2020

Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis

1 reference

12 December 2020

The role of anti-cyclic citrullinated peptide antibodies in predicting progression of palindromic rheumatism to rheumatoid arthritis

1 reference

12 December 2020

PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease

1 reference

12 December 2020

Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis

1 reference

12 December 2020

Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis.

1 reference

12 December 2020

Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome.

1 reference

12 December 2020

Role of anticyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test?

1 reference

12 December 2020

Predictive value of antibodies to cyclic citrullinated peptide in patients with early arthritis

1 reference

12 December 2020

Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.

1 reference

12 December 2020

Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?

1 reference

12 December 2020